Smart nanoparticles launch genetic attack on lung cancer and cystic fibrosis

A scientific team has unlocked a new way to treat serious lung conditions by using specially designed nanoparticles to deliver genetic therapies straight to lung cells. This innovation could transform care for patients with cystic fibrosis or lung cancer. With a powerful combination of gene editing and RNA delivery, the system has already shown promise in animal trials. The streamlined approach not only enhances precision but also avoids harmful side effects, making it a bold leap forward in respiratory medicine.